Cargando…

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function

Cancer immunotherapy using T cells redirected with chimeric antigen receptor (CAR) has shown a lot of promise. We have established a single-chain antibody (scFv) generation system in which scFv library-expressing CAR-T cells can be screened appropriately based on their antitumor functions. A variabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochi, Toshiki, Maruta, Masaki, Tanimoto, Kazushi, Kondo, Fumitake, Yamamoto, Toshihiro, Kurata, Mie, Fujiwara, Hiroshi, Masumoto, Junya, Takenaka, Katsuto, Yasukawa, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925539/ https://www.ncbi.nlm.nih.gov/pubmed/33654176 http://dx.doi.org/10.1038/s42003-021-01791-1

Ejemplares similares

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
por: Maruta, Masaki, et al.
Publicado: (2019)

Human herpesvirus 6 infection impairs Toll-like receptor signaling
por: Murakami, Yuichi, et al.
Publicado: (2010)

Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
por: Ochi, Toshiki, et al.
Publicado: (2010)

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy
por: Casey, Nicholas Paul, et al.
Publicado: (2016)

Reinforce the antitumor activity of CD8(+) T cells via glutamine restriction
por: Nabe, Shogo, et al.
Publicado: (2018)

Intestinal edema induced by LPS-induced endotoxemia is associated with an inflammasome adaptor ASC
por: Yamamoto, Toshihiro, et al.
Publicado: (2023)

The role of interleukin-1 in general pathology
por: Kaneko, Naoe, et al.
Publicado: (2019)

Inflammasome assembly is required for intracellular formation of β2-microglobulin amyloid fibrils, leading to IL-1β secretion
por: Kaneko, Naoe, et al.
Publicado: (2022)

Molecular biology of autoinflammatory diseases
por: Masumoto, Junya, et al.
Publicado: (2021)

Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
por: Yang, Quanjun, et al.
Publicado: (2022)

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
por: Schoutrop, Esther, et al.
Publicado: (2023)

IAPP/amylin deposition, which is correlated with expressions of ASC and IL-1β in β-cells of Langerhans’ islets, directly initiates NLRP3 inflammasome activation
por: Morikawa, Shinnosuke, et al.
Publicado: (2018)

Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation
por: Yamanouchi, Jun, et al.
Publicado: (2018)

Structure of the Signal Transduction Domain in Second-Generation CAR Regulates the Input Efficiency of CAR Signals
por: Fujiwara, Kento, et al.
Publicado: (2021)

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
por: Zhou, Jianxia, et al.
Publicado: (2019)

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor
por: Asai, Hiroaki, et al.
Publicado: (2013)

Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system
por: Nakanishi, Ayaka, et al.
Publicado: (2018)

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Applications of reconstituted inflammasomes in a cell-free system to drug discovery and elucidation of the pathogenesis of autoinflammatory diseases
por: Kaneko, Naoe, et al.
Publicado: (2017)

Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor Efficacy
por: Xia, Wenjiao, et al.
Publicado: (2023)

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022)

Subtypes of Familial Hemophagocytic Lymphohistiocytosis in Japan Based on Genetic and Functional Analyses of Cytotoxic T Lymphocytes
por: Nagai, Kozo, et al.
Publicado: (2010)

Are natural killer cells superior CAR drivers?
por: Klingemann, Hans
Publicado: (2014)

A simple mouse model of pericardial adhesions
por: Kojima, Ai, et al.
Publicado: (2019)

Hypoxic Culture Maintains Cell Growth of the Primary Human Valve Interstitial Cells with Stemness
por: Kanno, Kaho, et al.
Publicado: (2021)

CD21(lo) B Cells Could Be a Potential Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma
por: Nishimura, Kenichi, et al.
Publicado: (2022)

Arming NK cells with enhanced antitumor activity: CARs and beyond
por: Oberoi, Pranav, et al.
Publicado: (2013)

Incorporation of functional elements enhances the antitumor capacity of CAR T cells
por: Qin, Le, et al.
Publicado: (2017)

KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle–Wells syndrome
por: Kaneko, Naoe, et al.
Publicado: (2020)

Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T-lymphocytes
por: Caruana, Ignazio, et al.
Publicado: (2015)

T-bet promotes potent antitumor activity of CD4(+) CAR T cells
por: Gacerez, Albert T, et al.
Publicado: (2018)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

Preclinical development of CD126 CAR-T cells with broad antitumor activity
por: Mishra, Ameet K., et al.
Publicado: (2021)

The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021)

Recent advances in the diagnosis and management of primary myelofibrosis
por: Takenaka, Katsuto, et al.
Publicado: (2018)

Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cells
por: Fujiwara, Hiroshi
Publicado: (2021)

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
por: Katz, Steven, et al.
Publicado: (2016)

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
por: Hu, Biliang, et al.
Publicado: (2017)

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019)

Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays
por: Wang, Xiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ec12f5004bl3c3uu22tef32ci